# EDGAR Filing Document

**Accession Number:** 0000845982
**File Stem:** 0001654954-26-005694
**Filing Date:** 2026-6
**Character Count:** 4860
**Document Hash:** 2079218eb79223125d3da72abca996ef
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-005694.hdr.sgml**: 20260604

**ACCESSION NUMBER**: 0001654954-26-005694

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260604

**FILED AS OF DATE**: 20260604

**DATE AS OF CHANGE**: 20260604

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SMITH & NEPHEW PLC
- **CENTRAL INDEX KEY:** 0000845982
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14978
- **FILM NUMBER:** 261063739

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING 5, CROXLEY PARK
- **STREET 2:** HATTERS LANE
- **CITY:** WATFORD, HERTFORDSHIRE
- **PROVINCE COUNTRY:** X0
- **ZIP:** WD18 8YE
- **BUSINESS PHONE:** 44 (0) 1923 477 100

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING 5, CROXLEY PARK
- **STREET 2:** HATTERS LANE
- **CITY:** WATFORD, HERTFORDSHIRE
- **PROVINCE COUNTRY:** X0
- **ZIP:** WD18 8YE

 **UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **Form 6-K**

 **Report of Foreign Private Issuer**

 **Pursuant to Rule 13a-16 or 15d-16 under the**

 **Securities Exchange Act of 1934**

June 04, 2026

Commission File Number 001-14978

 **SMITH & NEPHEW plc**

(Registrant's name)

 **Building 5, Croxley Park, Hatters Lane**

 **Watford, England, WD18 8YE**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F <u>✔</u> Form 40-F __

 **SMITH & NEPHEW PLC**

4 June 2026

 **NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM**

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

Smith & Nephew plc (the "Company") received notification of the following transactions as detailed below.

---

| | |
|:---|:---|
| **Reason for the notification** | **Reason for the notification** |
| Initial notification /Amendment | Initial notification<br>|
| **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| Name | Smith & Nephew plc<br>|
| LEI | 213800ZTMDN8S67S1H61<br>|
| **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted** | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted** |
| Description of the financial instrument, type of instrument<br>| Smith & Nephew plc SPON ADR American Depositary Shares (ADS)<br>|
| Identification code | ISIN: US83175M2052<br>|
| Nature of the transaction | Director and PDMRs are participants of the Company's Employee Stock Purchase Plan, which purchased American Depository Shares through the Company's Dividend Re-Investment Plan following the 2025 final dividend payment on 27 May 2026.<br>|
| Date of Transaction | 2026-06-03<br>|
| Place of Transaction | New York Stock Exchange<br>|

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**<br>| **Director / PDMR**<br>| **Price ($)**<br>| **Volume**<br>| **Aggregated information**<br>|
| Deepak Nath<br> (Chief Executive Officer)<br>| Director<br>| 29.8328<br>| 52.17441<br>| N/A Single Transaction<br>|
| Mizanu Kebede<br> (Chief Quality & Regulatory Affairs Officer)<br>| PDMR<br>| 29.8328<br>| 22.19261<br>| N/A Single Transaction<br>|
| Paul Connolly<br> (President, Global Operations)<br>| PDMR<br>| 29.8328<br>| 52.00997<br>| N/A Single Transaction<br>|
| Scott Schaffner<br> (President, Sports Medicine)<br>| PDMR<br>| 29.8328<br>| 57.56604<br>| N/A Single Transaction<br>|

---

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

 **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  |  | **Smith & Nephew plc** |
|  |  | (Registrant) |
| Date: June 04, 2026 | By: | /s/ Helen Barraclough |
|  |  | Helen Barraclough |
|  |  | Company Secretary |

---